Sign Up to like & get
recommendations!
0
Published in 2025 at "Annals of Neurology"
DOI: 10.1002/ana.27201
Abstract: We aimed at evaluating the brain metabolic features of fused in sarcoma amyotrophic lateral sclerosis (FUS‐ALS) compared with sporadic ALS (sALS), using 2‐[fluorine‐18] fluoro‐2‐deoxy‐D‐glucose positron emission tomography (2‐[18F]FDG‐PET).
read more here.
Keywords:
fdg pet;
fus als;
18f fdg;
brain metabolic ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Frontiers in Molecular Neuroscience"
DOI: 10.3389/fnmol.2021.686995
Abstract: Mutations in the FUS gene cause amyotrophic lateral sclerosis (ALS-FUS). However, the exact pathogenic mechanism of mutant fused in sarcoma (FUS) protein is not completely understood. FUS is an RNA binding protein (RBP) localized predominantly…
read more here.
Keywords:
fus;
hdac inhibitors;
role;
inhibitors fus ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Applied Sciences"
DOI: 10.3390/app142411614
Abstract: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, often linked to mutations in the FUS gene, leading to toxic protein aggregates. This study investigates the role of HSP70, a molecular chaperone, in mitigating neurodegeneration…
read more here.
Keywords:
mouse models;
hsp70;
fus als;
als mouse ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms22158042
Abstract: Amyotrophic lateral sclerosis (ALS) is a progressive disease leading to the degeneration of motor neurons (MNs). Neuroinflammation is involved in the pathogenesis of ALS; however, interactions of specific immune cell types and MNs are not…
read more here.
Keywords:
th17 cells;
th17 lymphocytes;
th17;
degeneration ... See more keywords